IN THE METHOD §
This is a description in some detail of the sensitized sheep cell hemagglutination test for rheumatoid arthritis as it is currently carried out in this Clinic. Sustained interest in the pathogenesis, natural history, and treatment of rheumatoid arthritis leads us to direct a significant portion of the investigative studies toward improvements in the serological method with fairly exact definition of its diagnostic and prognostic value.
A lengthy test and the vagaries of rheumatoid arthritis suggest that the description of the method and its evaluation be treated separately. The poorly defined clinical landmarks of rheumatoid arthritis do indicate the need for such a diagnostic test. It is when the limits of clinical discernment and serological accuracy are mutually established that both can be used to full advantage. This report is rather strictly confined to the actual procedure. Data at hand will supply the material for its clinical counterpart. Meanwhile, Table 1 and a recent publication2 tell something of the performance of the hemagglutination test in rheumatoid arthritis. 3. Rabbit anti-sheep cell serum. This glycerinated hemolysin (equal parts of glycerin and hemolysin) is also obtained from a commercial source. A 1: 100 dilution is prepared as needed. Both the original supply and the stock dilution are stored at -10°C. The diluted hemolysin is discarded at the end of one week.
4. Glassware. Standard tubes (10 x 75 mm.) are used for the human serum throughout the method. Corks are included for storage.
METHOD. 1. Absorption of heterophile (naturally occurring) agglutinins.
To 0.4 ml. of human serum (inactivated at 560 C. for 30 minutes) is added 0.8 ml. of a 25 per cent sheep cell suspension. The tube (10 x 75 mm. dimensions) is shaken and allowed to stand at room temperature for 15 minutes. It is shaken again and centrifuged at 2,000 r.p.m. for 10 minutes. Another 0.8 ml. of cell suspension is added to the supernatant and the tube shaken. The absorption process is thus repeated for an additional 15 minutes at room temperature followed by refrigeration at 4°C. overnight or for a minimum of one hour if the serum is to be used the same day. The suspension is shaken and centrifuged. The absorbed serum, now in a 1: 4 dilution, is removed and used in the test or kept frozen at -10°C. The amount of easily removed serum is adequate for a repeat test, if needed.
A newer and less involved technique is the addition of 1.6 ml. of a 25 per cent sheep cell suspension to the 0.4 ml. of inactivated serum. The tube is shaken for a full minute and refrigerated. Absorption is started during the morning or early afternoon so that time allows a second and similar agitation. Centrifugation directly follows the overnight refrigeration.
Both methods are current. The latter is now routine, and the former is available when more than usual promptness is demanded. Information on the adequacy of both is included in the general discussion of the hemagglutination test which follows.
2. Titration of hemolysin. The dilution of hemolysin for the clinical test is established for each shipment of sheep cells. The desired amount is that which will agglutinate the cells at the established titer of the positive serum and clearly fail to cause agglutination in the normal serum. It is constant for each lot of cells but differs with the donor and even with the blood of the same sheep at another time. Two human serums are used. The one of known high titer is obtained from a patient with active rheumatoid arthritis, and the other is from an apparently healthy individual. The inactivated and absorbed control serums are from almost constant sources and are stored at -10°C. For convenience, a sample of the high titer serum for current use is diluted to one-fourth of its titer and kept frozen.
Two sets of tubes are arranged in racks to contain five rows of four each. One set is used for each control serum. Three-tenths ml. of saline is added to the tubes. Serum in like quantity is placed in the first tube of each set. It is mixed and 0.3 ml. is carried by a pipette from tube to tube. The twofold serial dilutions of the normal serum are from 1: 8 through 1: 64 and those of the rheumatoid serum from 1: 64 through 1: 512. There are no control tubes since completeness of absorption was confirmed at an earlier time.
Five dilutions of the stock (1: 100) hemolysin are usual. Concentrations are in the even numbers of 1: 4,000 through 1: 12,000. An additional tube (1: 14,000) is occasionally indicated by recorded titrations with cells from a certain sheep. Experience allows ready interpolation to the nearest one thousand and a finer expression of hemolysin dilution is not considered practical.
Two milliliter amounts of 1.0 per cent red cells in saline are sensitized by addition to an equal aliquot of each dilution of hemolysin. The mixture is incubated in a water bath at 37.5°C. for 15 minutes and 0.3 ml. of even suspension is pipetted into each of the eight tubes. Thorough agitation of the racks is directly followed by overnight refrigeration. Incubation at 37.5°C. for one hour is no longer employed since the slight increase in titer is obtained at the expense of sharpness of pattern.
The desired pattern in both serums should be obtained without difficulty as the amount of hemolysin should not be so critical that some leeway does not exist. Sheep cells which are unsatisfactory are reserved for the absorption of serums, and re-titration includes the cells of another sheep. The results are regularly reproduced in the actual test where the two standard serums are again used.
3. Clinical test. A row of nine tubes is used for each sample of inactivated and absorbed serum. Saline in 0.3 ml. amounts is added to the last eight tubes. Three-tenths milliliters of patient's serum is placed in both the first and second tubes. It is mixed in the second tube and carried to produce twofold dilutions from 1: 8 through 1: 1,024. The first tube of a row contains serum in a 1: 4 dilution for the detection of incomplete removal of heterophile antibodies. Dilutions of the two standard serums are limited to four. 4. Results. The appearance of the settled red cells determines the test result (Fig. 1) . Titer is expressed in units as the reciprocal of serum dilution. A range of less than eight units through 1,024 units is usually more than adequate for testing. The positive and negative standard serums must give the expected reactions and adequate removal of heterophile agglutinins shown.
Patterns are observed effectively from below by holding the tilted tube (about 40 degrees) at eye level against good light. The typical "negative" pattern is compact and usually sharply defined. It best presents as a small red disc in the control tube when absorption is complete. In tubes containing sensitized cells the disc is usually larger and has a light center of varying size.
Reactions are graded one through four according to the extent of distortion at the periphery. The basic positive pattern is a thin film of cells which covers the bottom of the tube. Clumping of red cells to form a side is a one plus, and a square is a four plus. Two-and three-sided figures give the intermediate grades of two plus and three plus. These are the usual designs. Hexagons, pentagons, and triangles are assigned a four plus since there is complete loss of circular form. Clumping at the circumference of an N pattern is a one or two plus according to degree. The N or basic positive pattern and cupping with a less than linear distortion are recorded but are not yet used as the endpoint. Their inclusion will further increase titer and yet maintain specificity. In practice, a reaction of one plus or more places the titer, and a titer of eight units is a positive test.
DISCUSSION
The hemagglutination test for rheumatoid arthritis is described at some length from titration of the reagents to interpretation of results. This particular method has been in active use for over two years. Experience with the various modifications of the test extends over a longer but less continuous period of time. These modifications were originally used in the screening search for a single basic and fairly sensitive test. They are again encountered by necessity in the evaluation of recent highly encouraging refinements8"'5 by others. Modifications occur naturally in the development of a test and lead to improvement. They can be too numerous, and a cumulative effect is felt when the new methods are imposed on diverse ones. A standard basic method permits ready evaluation of these promising refinements which deal principally with fractions of serum rather than whole serum.
The method as described detects the agglutination of sheep cells by settled pattern rather than by agitation. This is a more effective means since the titers of rheumatoid patients are unchanged or increased, while the serums of most nonrheumatoid individuals will fail to react within the visual range of the test. This is more than a matter of personal preference since the real range of the test becomes extended by the inclusion of the lower and now significant titers.
The total effects are not in conflict since less hemolysin is needed. It is the efforts to increase sensitivity by use of more hemolysin that have been ineffectual through an inordinate loss of specificity. This is apparent from the direct comparison of methods. It is expressed in a somewhat different way in the study of This present method is suggested as a standard method. High selectivity is obtained without apparent alteration of the basic factors. Its nature suggests that more of the total mechanism is open to inspection. Both quality and consistency are important for accuracy in the appraisal of promising refinements.
The few other changes in the hemagglutination test are of a streamlining nature. The absorption procedure is the most effectual timesaver of all. Failure to remove adequately heterophile antibodies is so unusual that no effort is made to supply comparative figures. The following facts are immediately available. Absorption was incomplete in one of the serums from 121 recent patients (first method with refrigeration for two hours). This incidence of less than one per cent is known to be high. Removal was complete from all serums of 203 patients in a later group (second method). The treatment of exceptional serums is not yet uniform because of their infrequency and the efficacy of the usual means at hand. The process may be started anew with another 0.4 ml. sample of inactivated serum. Agitation and refrigeration is lengthened. A new lot of sheep cells is at times used. This means is usually preferred since the method remains constant. Time and inadequacy of serum would favor the alternative of an addition of 0.8 ml. of cells to 0.6 ml. of the partially absorbed serum. The regular dilutions are maintained quite readily. There is loss of a safety factor since the concentration of serum in the control tube and first tube of the test is the same ( 1: 8) .
Although serum is used with continuing regularity in this laboratory, reference should be made to the use of plasma in the test. The following comparison was prompted in part by an early situation where only an oxalated sample of blood was available for the determination. The sources of plasma and serum for the parallel tests were 29 patients and 5 healthy adults. The patients were clinically distributed as: rheumatoid arthritis, 20; rheumatoid arthritis with psoriasis, 1; osteoarthritis, 7; and gout, 1. Those with rheumatoid arthritis included four whose tests had returned to nega- tive and one with only negative tests on record. The titers of plasma and serum matched in 32 instances. Two individuals with rheumatoid arthritis had plasma titers of 512 units and serum titers of 256 units. There was no shift of result from negative to positive even with the five rheumatoid patients. For these and other reasons, the increase is without import.
Neither absorption nor red cell pattern was affected. This is evidence that in usual laboratory practice plasma and serum can be used quite interchangeably as dictated by convenience or need. Table 1 summarizes with minimal detail the results of the hemagglutination test in 200 patients. It is included since strict adherence to method may be unduly limiting in this discussion of a clinical test. Attention is called to the manner of selection of the patients. The primary source was the files of the Streptococcus laboratory which include many with rheumatic diseases. Clinical behavior of the test is assessed from the results in well-established illnesses, both rheumatoid and nonrheumatoid. The number in each group was limited to 100 adults. The rheumatoid patients have "textbook" rheumatoid arthritis and the result of the hemagglutination test tabulated is that of the initial determination. Similarly, the individuals in the control group have an accurately defined presenting illness without overt rheumatoid arthritis. This should result in approximate information on sensitivity and selectivity with a somewhat high incidence of positive tests in both groups.
The data in Table 1 place the diagnostic effectiveness of the hemagglutination test at about 90 per cent (189 of 200 patients). Information obtained from other studies in this clinic indicates that the figures have a broad validity. The failure of the method to support the clinical impression in the 11 patients lacks full explanation.
SUMMARY
The hemagglutination test for rheumatoid arthritis as described offers the high selectivity and sharp results which are requirements for a practical test. It should serve as a satisfactory standard method for new and special refinements.
